| S3716 |
Flibanserin
|
Flibanserin (BIMT-17, BIMT-17-BS) is a nonhormonal, centrally acting molecule that acts as an agonist at postsynaptic 5-HT1A receptors and as an antagonist at 5-HT2A receptors.
|
-
Arch Biochem Biophys, 2024, 754:109958
-
Nat Commun, 2021, 12(1):5919
|
|
| S5858 |
Vilazodone
|
Vilazodone (EMD-68843, SB-659746A) is a novel antidepressant having a selective serotonin (5-HT) reuptake inhibitory and 5-HT1A receptor partial agonist activity. The affinity of vilazodone is much higher in the 5-HT reuptake site (Ki=0.1 nM) than in norepinephrine (Ki=56 nM) and dopamine (Ki=37 nM) sites.
|
-
J Pain, 2019, 20(1):16.e1-16.e16
|
|
| S5843 |
Cinitapride Hydrogen Tartrate
|
Cinitapride Hydrogen Tartrate is a gastroprokinetic agent that acts as an agonist of the 5-HT1 and 5-HT4 receptors and as an antagonist of the 5-HT2 receptors
|
|
|
| S5949 |
Metoclopramide hydrochloride hydrate
|
Metoclopramide hydrochloride (Clorpa, Gimoti, Maxolon, Reglan) hydrate is primarily a Dopamine receptor antagonist, with 5HT3 receptor antagonist and 5HT4 receptor agonist activity, and used as an antiemetic and gastroprokinetic.
|
-
Anticancer Drugs, 2022, 10.1097/CAD.0000000000001344
-
Pharmazie, 2021, 76(4):172-174
|
|